Skip to main content

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Deep Track Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
5
Since Q4 2021
Holdings of CRNX by Deep Track Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−1,048,829−100.0%Sold outHolders
Q4 20221,048,829$19.2M0.8%−4,171−0.4%ReducedHolders
Q3 20221,053,000$20.7M1.0%00.0%UnchangedHolders
Q2 20221,053,000$19.6M1.4%−488,715−31.7%ReducedHolders
Q1 20221,541,715$33.8M2.2%−358,285−18.9%ReducedHolders
Q4 20211,900,000$54.0M4.0%–No prior filingHolders